findmyKOL

Guillaume Lamotte, MD

Basic profile

Neurology

ORCID↗NPI↗
RegionRochester, MN · MidwestSpecialtyNeurologyFocusNeurology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Guillaume Lamotte is a Neurology physician. OpenAlex indexes 113 publications with 1,895 citations (h-index 20).

Overview

Scholarship

indexed output and impact (OpenAlex)
113publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,895citations

Total citations across indexed works.

20h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

200 1st St SW
Rochester, MN 559050001

Telephone

507-284-2511

Provider last certified this registry record 17 Nov 2021.

View the NPPES registry record

Industry payments

2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    86%
    Aromatic Amino Acid Decarboxylation Inhibitor42.3%
    Carbidopa-Levodopa76%Carbidopa-Levodopa Er22%Rytary3%
    Part D<11 patients
    Cholinesterase Inhibitor13%
    Donepezil Hcl54%Pyridostigmine Bromide36%Rivastigmine10%
    Part D<11 patients

    + 12 more classes in this area

  • Cardiovascular

    13.2%
    alpha-Adrenergic Agonist4.7%
    Midodrine Hcl100%
    Part D≥25 patients
    Beta blocker2.8%
    Propranolol Hcl51%Propranolol Hcl Er49%
    Part D<11 patients

    + 3 more classes in this area

  • Hormonal (systemic)

    0.8%
    Mineralocorticoids0.8%
    Fludrocortisone Acetate100%
    Part D<11 patients
Where care is delivered (Part B)13.9% facility · 86.1% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”